Abstract
Intermittent claudication is a potentially disabling disorder that impairs quality of life and is a marker of underlying cardiovascular disease. Treatment involves secondary prevention and measures to improve walking. Cilostazol significantly increases walking distance and quality of life in claudicants.
| Original language | English |
|---|---|
| Pages (from-to) | 466-470 |
| Number of pages | 4 |
| Journal | Hospital Medicine |
| Volume | 65 |
| Publication status | Published - 2004 |
Keywords
- PERIPHERAL ARTERIAL-DISEASE
- QUALITY-OF-LIFE
- CARDIOVASCULAR EVENTS
- CONTROLLED TRIALS
- VASCULAR-DISEASE
- METAANALYSIS
- WALKING
- MULTICENTER
- PREVENTION
- MANAGEMENT
